{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:53:44Z","timestamp":1793055224353,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,3,10]],"date-time":"2013-03-10T00:00:00Z","timestamp":1362873600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s12664-013-0315-4","type":"journal-article","created":{"date-parts":[[2013,3,9]],"date-time":"2013-03-09T02:24:23Z","timestamp":1362795863000},"page":"268-271","source":"Crossref","is-referenced-by-count":10,"title":["Preliminary experience with use of recombinant activated factor VII to control postpartum hemorrhage in acute fatty liver of pregnancy and other pregnancy-related liver disorders"],"prefix":"10.1007","volume":"32","author":[{"given":"Ashish","family":"Goel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukesh Chandran","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auro","family":"Viswabandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinodh P.","family":"Masilamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoma V.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Regi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby","family":"Jose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday","family":"Zachariah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandasamy","family":"Subramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. E.","family":"Eapen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Chandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,10]]},"reference":[{"key":"315_CR1","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.20123","volume":"39","author":"SH Caldwell","year":"2004","unstructured":"Caldwell SH, Chang C, Macik BG. Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: a break from convention in need of controlled trials. Hepatology. 2004;39:592\u20138.","journal-title":"Hepatology"},{"key":"315_CR2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/GRF.0b013e3181cc4378","volume":"53","author":"M Franchini","year":"2010","unstructured":"Franchini M, Franchi M, Bergamini V, et al. The use of recombinant activated FVII in postpartum hemorrhage. Clin Obstet Gynecol. 2010;53:219\u201327.","journal-title":"Clin Obstet Gynecol"},{"key":"315_CR3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/MBC.0b013e32830496a7","volume":"19","author":"M Franchini","year":"2008","unstructured":"Franchini M, Montagnana M, Targher G, Zaffanello M, Lippi G. The use of recombinant factor VIIa in liver diseases. Blood Coagul Fibrinolysis. 2008;19:341\u20138.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"315_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2125.2007.03030.x","volume":"65","author":"T Klitgaard","year":"2008","unstructured":"Klitgaard T, Nielsen TG. Overview of the human pharmacokinetics of recombinant activated factor VII. Br J Clin Pharmacol. 2008;65:3\u201311.","journal-title":"Br J Clin Pharmacol"},{"key":"315_CR5","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1503\/cmaj.100408","volume":"183","author":"Y Lin","year":"2011","unstructured":"Lin Y, Stanworth S, Birchall J, Doree C, Hyde C. Use of recombinant factor VIIa for the prevention and treatment of bleeding in patients without hemophilia: a systematic review and meta-analysis. CMAJ. 2011;183:E9\u201319.","journal-title":"CMAJ"},{"key":"315_CR6","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/cc5026","volume":"10","author":"JL Vincent","year":"2006","unstructured":"Vincent JL, Rossaint R, Riou B, Ozier Y, Zideman D, Spahn DR. Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding\u2014a European perspective. Crit Care. 2006;10:R120.","journal-title":"Crit Care"},{"key":"315_CR7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1479-828X.2007.00823.x","volume":"48","author":"A Welsh","year":"2008","unstructured":"Welsh A, McLintock C, Gatt S, Somerset D, Popham P, Ogle R. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Aust N Z J Obstet Gynaecol. 2008;48:12\u20136.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"315_CR8","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/01.AOG.0000127943.68645.96","volume":"103","author":"SH Merchant","year":"2004","unstructured":"Merchant SH, Mathew P, Vanderjagt TJ, Howdieshell TR, Crookston KP. Recombinant factor VIIa in management of spontaneous subcapsular liver hematoma associated with pregnancy. Obstet Gynecol. 2004;103:1055\u20138.","journal-title":"Obstet Gynecol"},{"key":"315_CR9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1471-0528.2006.01156.x","volume":"114","author":"M Franchini","year":"2007","unstructured":"Franchini M, Lippi G, Franchi M. The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage. BJOG. 2007;114:8\u201315.","journal-title":"BJOG"},{"key":"315_CR10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/0310057X0503300207","volume":"33","author":"CJ Gowers","year":"2005","unstructured":"Gowers CJ, Parr MJ. Recombinant activated factor VIIa use in massive transfusion and coagulopathy unresponsive to conventional therapy. Anaesth Intensive Care. 2005;33:196\u2013200.","journal-title":"Anaesth Intensive Care"},{"key":"315_CR11","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1213\/ANE.0b013e3181c039e6","volume":"109","author":"LE Phillips","year":"2009","unstructured":"Phillips LE, McLintock C, Pollock W, et al. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. Anesth Analg. 2009;109:1908\u201315.","journal-title":"Anesth Analg"},{"key":"315_CR12","first-page":"390","volume":"67","author":"S Singh","year":"2011","unstructured":"Singh S, Menon A, Thareja S. Recombinant activated factor VIIa in a case of pregnancy with acute hepatic failure and massive blood loss. MJAFI. 2011;67:390\u20133.","journal-title":"MJAFI"},{"key":"315_CR13","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gut.51.6.876","volume":"51","author":"CL Ch'ng","year":"2002","unstructured":"Ch'ng CL, Morgan M, Hainsworth I, Kingham JG. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut. 2002;51:876\u201380.","journal-title":"Gut"},{"key":"315_CR14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/gut.2009.198465","volume":"60","author":"A Goel","year":"2011","unstructured":"Goel A, Ramakrishna B, Zachariah U, et al. How accurate are the Swansea criteria to diagnose acute fatty liver of pregnancy in predicting hepatic microvesicular steatosis? Gut. 2011;60:138\u20139.","journal-title":"Gut"},{"key":"315_CR15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/gast.2002.34164","volume":"123","author":"L Jeffers","year":"2002","unstructured":"Jeffers L, Chalasani N, Balart L, Pyrsopoulos N, Erhardtsen E. Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy. Gastroenterology. 2002;123:118\u201326.","journal-title":"Gastroenterology"},{"key":"315_CR16","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1023\/A:1024144217614","volume":"48","author":"A Anantharaju","year":"2003","unstructured":"Anantharaju A, Mehta K, Mindikoglu AL, Van Thiel DH. Use of activated recombinant human factor VII (rhFVIIa) for colonic polypectomies in patients with cirrhosis and coagulopathy. Dig Dis Sci. 2003;48:1414\u201324.","journal-title":"Dig Dis Sci"},{"key":"315_CR17","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1345\/aph.1Q207","volume":"45","author":"JC Krisl","year":"2011","unstructured":"Krisl JC, Meadows HE, Greenberg CS, Mazur JE. Clinical usefulness of recombinant activated factor VII in patients with liver failure undergoing invasive procedures. Ann Pharmacother. 2011;45:1433\u20138.","journal-title":"Ann Pharmacother"},{"key":"315_CR18","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/hep.22216","volume":"47","author":"J Bosch","year":"2008","unstructured":"Bosch J, Thabut D, Albillos A, et al. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial. Hepatology. 2008;47:1604\u201314.","journal-title":"Hepatology"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-013-0315-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12664-013-0315-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-013-0315-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T18:27:02Z","timestamp":1562783222000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12664-013-0315-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,10]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["315"],"URL":"https:\/\/doi.org\/10.1007\/s12664-013-0315-4","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,10]]}}}